{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T22:16:32Z","timestamp":1788128192681,"version":"build-2803163510"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-026-01456-1","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:17:13Z","timestamp":1786609033000},"page":"1152-1168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiation-induced CD200+ tumor-associated macrophages suppress eosinophil-mediated antitumor immunity through CD200R signaling in hepatocellular carcinoma"],"prefix":"10.1038","volume":"23","author":[{"given":"Kun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbo","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiusheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4981-4745","authenticated-orcid":false,"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"1456_CR1","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.trecan.2016.09.007","volume":"2","author":"W Jiang","year":"2016","unstructured":"Jiang W, Chan CK, Weissman IL, Kim BYS, Hahn SM. Immune priming of the tumor microenvironment by radiation. Trends Cancer. 2016;2:638\u201345.","journal-title":"Trends Cancer"},{"key":"1456_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41568-020-0246-1","volume":"20","author":"M McLaughlin","year":"2020","unstructured":"McLaughlin M, Patin EC, Pedersen M, Wilkins A, Dillon MT, Melcher AA,\u00a0et al. Inflammatory microenvironment remodeling by tumor cells after radiotherapy. Nat Rev Cancer. 2020;20:203\u201317.","journal-title":"Nat Rev Cancer"},{"key":"1456_CR3","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1016\/S1470-2045(15)00007-8","volume":"16","author":"AB Sharabi","year":"2015","unstructured":"Sharabi AB, Lim M, DeWeese TL, Drake CG. Radiation and checkpoint blockade immunotherapy: radiosensitization and potential mechanisms of synergy. Lancet Oncol. 2015;16:e498\u2013509.","journal-title":"Lancet Oncol"},{"key":"1456_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature14292","volume":"520","author":"C Twyman-Saint Victor","year":"2015","unstructured":"Twyman-Saint Victor C, Rech AJ, Maity A, Rengan R, Pauken KE, Stelekati E,\u00a0et al. Radiation and dual checkpoint blockade activate nonredundant immune mechanisms in cancer. Nature. 2015;520:373\u20137.","journal-title":"Nature"},{"key":"1456_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abg0117","volume":"6","author":"J Wei","year":"2021","unstructured":"Wei J, Montalvo-Ortiz W, Yu L, Krasco A, Ebstein S, Cortez C,\u00a0et al. Sequence of \u03b1PD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses. Sci Immunol. 2021;6:eabg0117.","journal-title":"Sci Immunol"},{"key":"1456_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01566-5","volume":"8","author":"H Liang","year":"2017","unstructured":"Liang H, Deng L, Hou Y, Meng X, Huang X, Rao E,\u00a0et al. Host STING-dependent MDSC mobilization drives extrinsic radiation resistance. Nat Commun. 2017;8:1736.","journal-title":"Nat Commun"},{"key":"1456_CR7","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.ccell.2021.08.008","volume":"39","author":"Y Lan","year":"2021","unstructured":"Lan Y, Moustafa M, Knoll M, Xu C, Furkel J, Lazorchak A, et al. Simultaneous targeting of TGF-\u03b2\/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion. Cancer Cell. 2021;39:1388\u20131403.e10.","journal-title":"Cancer Cell"},{"key":"1456_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nrc3958","volume":"15","author":"HE Barker","year":"2015","unstructured":"Barker HE, Paget JT, Khan AA, Harrington KJ. The tumor microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015;15:409\u201325.","journal-title":"Nat Rev Cancer"},{"key":"1456_CR9","first-page":"65","volume":"67","author":"FG Herrera","year":"2017","unstructured":"Herrera FG, Bourhis J, Coukos G. Radiotherapy combination opportunities leveraging immunity for the next oncology practice. CA Cancer J Clin. 2017;67:65\u201385.","journal-title":"CA Cancer J Clin"},{"key":"1456_CR10","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, He Y, Luo N, Patel SJ, Han Y, Gao R, et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell. 2019;179:829\u2013845.e20.","journal-title":"Cell"},{"key":"1456_CR11","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/hep.32740","volume":"77","author":"R Donne","year":"2023","unstructured":"Donne R, Lujambio A.\u00a0The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma. Hepatology. 2023;77:1773\u201396.","journal-title":"Hepatology"},{"key":"1456_CR12","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ccell.2024.04.002","volume":"42","author":"C Bl\u00e9riot","year":"2024","unstructured":"Bl\u00e9riot C, Dunsmore G, Alonso-Curbelo D, Ginhoux F. A temporal perspective for tumor-associated macrophage identities and functions. Cancer Cell. 2024;42:747\u201358.","journal-title":"Cancer Cell"},{"key":"1456_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3350\/cmh.2021.0308","volume":"28","author":"PS Sung","year":"2022","unstructured":"Sung, PS. Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma. Clin Mol Hepatol. 2022;28:333\u201350.","journal-title":"Clin Mol Hepatol"},{"key":"1456_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jhep.2023.02.032","volume":"79","author":"J Tan","year":"2023","unstructured":"Tan J, Fan W, Liu T, Zhu B, Liu Y, Wang S, et al. TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma. J Hepatol. 2023;79:126\u201340.","journal-title":"J Hepatol"},{"key":"1456_CR15","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1016\/j.cell.2023.07.026","volume":"186","author":"B Ruf","year":"2023","unstructured":"Ruf B, Bruhns M, Babaei S, Kedei N, Ma L, Revsine M,\u00a0et al. Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin. Cell. 2023;186:3686\u20133705.e32.","journal-title":"Cell"},{"key":"1456_CR16","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.cell.2023.02.020","volume":"186","author":"DJ Kloosterman","year":"2023","unstructured":"Kloosterman DJ, Akkari L. Macrophages at the interface of the coevolving cancer ecosystem. Cell. 2023;186:1627\u201351.","journal-title":"Cell"},{"key":"1456_CR17","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","volume":"52","author":"MEW Logtenberg","year":"2020","unstructured":"Logtenberg MEW, Scheeren FA, Schumacher TN.\u00a0The CD47-SIRP\u03b1 immune checkpoint. Immunity. 2020;52:742\u201352.","journal-title":"Immunity"},{"key":"1456_CR18","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s43018-022-00456-0","volume":"3","author":"Y Nishiga","year":"2022","unstructured":"Nishiga Y, Drainas AP, Baron M, Bhattacharya D, Barkal AA, Ahrari Y, et al. Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect. Nat Cancer. 2022;3:1351\u201366.","journal-title":"Nat Cancer"},{"key":"1456_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.trecan.2023.11.009","volume":"10","author":"K Boelaars","year":"2024","unstructured":"Boelaars K, van Kooyk Y.\u00a0Targeting myeloid cells for cancer immunotherapy: Siglec-7\/9\/10\/15 and their ligands. Trends Cancer. 2024;10:230\u201341.","journal-title":"Trends Cancer"},{"key":"1456_CR20","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s43018-023-00598-9","volume":"4","author":"Y Mei","year":"2023","unstructured":"Mei Y, Wang X, Zhang J, Liu D, He J, Huang C, et al. Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response. Nat Cancer. 2023;4:1273\u201391.","journal-title":"Nat Cancer"},{"key":"1456_CR21","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1158\/2326-6066.CIR-18-0489","volume":"7","author":"W Xu","year":"2019","unstructured":"Xu W, Dong J, Zheng Y, Zhou J, Yuan Y, Ta HM, et al. Immune-checkpoint protein VISTA regulates antitumor immunity by controlling myeloid cell-mediated inflammation and immunosuppression. Cancer Immunol Res. 2019;7:1497\u2013510.","journal-title":"Cancer Immunol Res"},{"key":"1456_CR22","doi-asserted-by":"crossref","unstructured":"Yang X, Huang R, Fang M, He Y, Xie J, Liu X, et al. Secretogranin 2 binds LILRB4 resulting in immunosuppression. Nat Immunol. 2025;26:1567-1580.","DOI":"10.1038\/s41590-025-02233-4"},{"key":"1456_CR23","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1126\/science.290.5497.1768","volume":"290","author":"RM Hoek","year":"2000","unstructured":"Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, Zurawski SM, et al. Downregulation of the macrophage lineage through interaction with OX2 (CD200). Science. 2000;290:1768\u201371.","journal-title":"Science"},{"key":"1456_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1471-4906(02)02223-8","volume":"23","author":"AN Barclay","year":"2002","unstructured":"Barclay AN, Wright GJ, Brooke G, Brown MH. CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol. 2002;23:285\u201390.","journal-title":"Trends Immunol"},{"key":"1456_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60456-3","volume":"16","author":"J Li","year":"2025","unstructured":"Li J, Wang Z, Qin X, Zhong MC, Tang Z, Qian J, et al. CD200R1-CD200 checkpoint inhibits phagocytosis differently from SIRP\u03b1-CD47 to suppress tumor growth. Nat Commun. 2025;16:5145.","journal-title":"Nat Commun"},{"key":"1456_CR26","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.1158\/0008-5472.CAN-20-3251","volume":"81","author":"IZ Khan","year":"2021","unstructured":"Khan IZ, Del Guzzo CA, Shao A, Cho J, Du R, Cohen AO, et al. The CD200-CD200R axis promotes squamous cell carcinoma metastasis via regulation of cathepsin K. Cancer Res. 2021;81:5021\u201332.","journal-title":"Cancer Res"},{"key":"1456_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41423-024-01136-y","volume":"21","author":"YS Kim","year":"2024","unstructured":"Kim YS, Jeong YS, Bae GH, Kang JH, Lee M, Zabel BA, et al. CD200Rhigh neutrophils with dysfunctional autophagy establish systemic immunosuppression by increasing regulatory T cells. Cell Mol Immunol. 2024;21:349\u201361.","journal-title":"Cell Mol Immunol"},{"key":"1456_CR28","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.chom.2010.08.005","volume":"8","author":"S Mukhopadhyay","year":"2010","unstructured":"Mukhopadhyay S, Pl\u00fcddemann A, Hoe JC, Williams KJ, Varin A, Makepeace K,\u00a0et al. Immune inhibitory ligand CD200 induction by TLRs and NLRs limits macrophage activation to protect the host from meningococcal septicemia. Cell Host Microbe. 2010;8:236\u201347.","journal-title":"Cell Host Microbe"},{"key":"1456_CR29","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.chom.2011.04.014","volume":"9","author":"M Cortez","year":"2011","unstructured":"Cortez M, Huynh C, Fernandes MC, Kennedy KA, Aderem A, Andrews NW.\u00a0Leishmania promotes its own virulence by inducing expression of the host immune inhibitory ligand CD200. Cell Host Microbe. 2011;9:463\u201371.","journal-title":"Cell Host Microbe"},{"key":"1456_CR30","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41590-024-01774-4","volume":"25","author":"S Rauber","year":"2024","unstructured":"Rauber S, Mohammadian H, Schmidkonz C, Atzinger A, Soare A, Treutlein C,\u00a0et al. CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis. Nat Immunol. 2024;25:682\u201392.","journal-title":"Nat Immunol"},{"key":"1456_CR31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1161\/CIRCRESAHA.119.316062","volume":"129","author":"C Kassiteridi","year":"2021","unstructured":"Kassiteridi C, Cole JE, Griseri T, Falck-Hansen M, Goddard ME, Seneviratne AN, et al. CD200 limits monopoiesis and monocyte recruitment in atherosclerosis. Circ Res. 2021;129:280\u201395.","journal-title":"Circ Res"},{"key":"1456_CR32","unstructured":"Grisaru-Tal S, Jacobsen EA, Munitz A. Evolving role for eosinophils in cancer: from bench to bedside. Trends Cancer. 2025 Jun 12:S2405-8033(25)00131-1."},{"key":"1456_CR33","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/s41590-022-01291-2","volume":"23","author":"S Grisaru-Tal","year":"2022","unstructured":"Grisaru-Tal S, Rothenberg ME, Munitz A.\u00a0Eosinophil-lymphocyte interactions in the tumor microenvironment and cancer immunotherapy. Nat Immunol. 2022;23:1309\u201316.","journal-title":"Nat Immunol"},{"key":"1456_CR34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ccell.2022.11.014","volume":"41","author":"OS Blomberg","year":"2023","unstructured":"Blomberg OS, Spagnuolo L, Garner H, Voorwerk L, Isaeva OI, van Dyk E,\u00a0et al. IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer. Cancer Cell. 2023;41:106\u2013123.e10.","journal-title":"Cancer Cell"},{"key":"1456_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1158\/2326-6066.CIR-18-0494","volume":"7","author":"H Reichman","year":"2019","unstructured":"Reichman H, Itan M, Rozenberg P, Yarmolovski T, Brazowski E, Varol C, et al. Activated eosinophils exert antitumorigenic activities in colorectal cancer. Cancer Immunol Res. 2019;7:388\u2013400.","journal-title":"Cancer Immunol Res"},{"key":"1456_CR36","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc7609","volume":"7","author":"JN Cheng","year":"2021","unstructured":"Cheng JN, Luo W, Sun C, Jin Z, Zeng X, Alexander PB,\u00a0et al. Radiation-induced eosinophils improve cytotoxic T lymphocyte recruitment and response to immunotherapy. Sci Adv. 2021;7:eabc7609.","journal-title":"Sci Adv"},{"key":"1456_CR37","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","volume":"41","author":"L Deng","year":"2014","unstructured":"Deng L, Liang H, Xu M, Yang X, Burnette B, Arina A, et al. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity. 2014;41:843\u201352.","journal-title":"Immunity"},{"key":"1456_CR38","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41589-021-00918-z","volume":"18","author":"Z Shao","year":"2022","unstructured":"Shao Z, Shen Q, Yao B, Mao C, Chen LN, Zhang H,\u00a0et al. Identification and mechanism of G protein-biased ligands for chemokine receptor CCR1. Nat Chem Biol. 2022;18:264\u201371.","journal-title":"Nat Chem Biol"},{"key":"1456_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41392-021-00482-x","volume":"6","author":"X Du","year":"2021","unstructured":"Du X, Li F, Zhang C, Li N, Huang H, Shao Z, et al. Eosinophil-derived chemokine (hCCL15\/23, mCCL6) interacts with CCR1 to promote eosinophilic airway inflammation. Signal Transduct Target Ther. 2021;6:91.","journal-title":"Signal Transduct Target Ther"},{"key":"1456_CR40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","volume":"612","author":"R Xue","year":"2022","unstructured":"Xue R, Zhang Q, Cao Q, Kong R, Xiang X, Liu H,\u00a0et al. Liver tumor immune microenvironment subtypes and neutrophil heterogeneity. Nature. 2022;612:141\u20137.","journal-title":"Nature"},{"key":"1456_CR41","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jhep.2022.10.037","volume":"78","author":"VW Yuen","year":"2023","unstructured":"Yuen VW, Chiu DK, Law CT, Cheu JW, Chan CY, Wong BP, et al. Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses. J Hepatol. 2023;78:376\u201389.","journal-title":"J Hepatol"},{"key":"1456_CR42","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","volume":"79","author":"AD Ladd","year":"2024","unstructured":"Ladd AD, Duarte S, Sahin I, Zarrinpar A. Mechanisms of drug resistance in HCC. Hepatology. 2024;79:926\u201340.","journal-title":"Hepatology"},{"key":"1456_CR43","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y Liu","year":"2023","unstructured":"Liu Y, Xun Z, Ma K, Liang S, Li X, Zhou S, et al.\u00a0Identification of a tumor immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J Hepatol. 2023;78:770\u201382.","journal-title":"J Hepatol"},{"key":"1456_CR44","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s43018-022-00357-2","volume":"3","author":"JM Llovet","year":"2022","unstructured":"Llovet JM, Pinyol R, Kelley RK, El-Khoueiry A, Reeves HL, Wang XW,\u00a0et al. Molecular pathogenesis and systemic therapies for hepatocellular carcinoma. Nat Cancer. 2022;3:386\u2013401.","journal-title":"Nat Cancer"},{"key":"1456_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41392-023-01462-z","volume":"8","author":"S Guo","year":"2023","unstructured":"Guo S, Yao Y, Tang Y, Xin Z, Wu D, Ni C, et al. Radiation-induced tumor immune microenvironments and potential targets for combination therapy. Signal Transduct Target Ther. 2023;8:205.","journal-title":"Signal Transduct Target Ther"},{"key":"1456_CR46","unstructured":"Wu Y, Lu WM, Cui QR, Zhou J, Lu GD. Metabolic Regulation of cGAS-STING signaling in the tumor microenvironment: dual immune roles and therapeutic implications. Cytokine Growth Factor Rev. 2025:S1359-6101(25)00074-7."},{"key":"1456_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.immuni.2020.06.009","volume":"53","author":"J Wu","year":"2020","unstructured":"Wu J, Dobbs N, Yang K, Yan N.\u00a0Interferon-independent activities of mammalian STING mediate antiviral response and tumor immune evasion. Immunity. 2020;53:115\u2013126.e5.","journal-title":"Immunity"},{"key":"1456_CR48","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41586-022-05254-3","volume":"610","author":"S Li","year":"2022","unstructured":"Li S, Mirlekar B, Johnson BM, Brickey WJ, Wrobel JA, Yang N,\u00a0et al. STING-induced regulatory B cells compromise NK function in cancer immunity. Nature. 2022;610:373\u201380.","journal-title":"Nature"},{"key":"1456_CR49","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41577-024-01112-7","volume":"25","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Zhang C.\u00a0Regulation of cGAS-STING signaling and its diversity of cellular outcomes. Nat Rev Immunol. 2025;25:425\u201344.","journal-title":"Nat Rev Immunol"},{"key":"1456_CR50","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1158\/0008-5472.CAN-21-0839","volume":"81","author":"S Grisaru-Tal","year":"2021","unstructured":"Grisaru-Tal S, Dulberg S, Beck L, Zhang C, Itan M, Hediyeh-Zadeh S, et al. Metastasis-entrained eosinophils enhance lymphocyte-mediated antitumor immunity. Cancer Res. 2021;81:5555\u201371.","journal-title":"Cancer Res"},{"key":"1456_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.802839","volume":"12","author":"A Dolitzky","year":"2021","unstructured":"Dolitzky A, Shapira G, Grisaru-Tal S, Hazut I, Avlas S, Gordon Y, et al. Transcriptional profiling of mouse eosinophils identifies distinct gene signatures following cellular activation. Front Immunol. 2021;12:802839.","journal-title":"Front Immunol"},{"key":"1456_CR52","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1073\/pnas.86.4.1348","volume":"86","author":"DR Lucey","year":"1989","unstructured":"Lucey DR, Nicholson-Weller A, Weller PF. Mature human eosinophils have the capacity to express HLA-DR. Proc Natl Acad Sci USA. 1989;86:1348\u201351.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1456_CR53","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1084\/jem.190.4.487","volume":"190","author":"G Woerly","year":"1999","unstructured":"Woerly G, Roger N, Loiseau S, Dombrowicz D, Capron A, Capron M. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexes. J Exp Med. 1999;190:487\u201395.","journal-title":"J Exp Med"},{"key":"1456_CR54","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4049\/jimmunol.177.1.77","volume":"177","author":"A Munitz","year":"2006","unstructured":"Munitz A, Bachelet I, Eliashar R, Khodoun M, Finkelman FD, Rothenberg ME, et al. CD48 is an allergen and IL-3-induced activation molecule on eosinophils. J Immunol. 2006;177:77\u201383.","journal-title":"J Immunol"},{"key":"1456_CR55","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/ni.3159","volume":"16","author":"R Carretero","year":"2015","unstructured":"Carretero R, Sektioglu IM, Garbi N, Salgado OC, Beckhove P, H\u00e4mmerling GJ. Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells. Nat Immunol. 2015;16:609\u201317.","journal-title":"Nat Immunol"},{"key":"1456_CR56","doi-asserted-by":"publisher","DOI":"10.1172\/JCI150750","volume":"132","author":"HJ Morgan","year":"2022","unstructured":"Morgan HJ, Rees E, Lanfredini S, Powell KA, Gore J, Gibbs A,\u00a0et al. CD200 ectodomain shedding into the tumor microenvironment leads to NK cell dysfunction and apoptosis. J Clin Invest. 2022;132:e150750.","journal-title":"J Clin Invest"},{"key":"1456_CR57","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1182\/blood.2022018658","volume":"143","author":"Y Tang","year":"2024","unstructured":"Tang Y, Liu W, Kadu S, Johnson O, Hasanali ZS, Kelly A, et al. Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy. Blood. 2024;143:139\u201351.","journal-title":"Blood"},{"key":"1456_CR58","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1016\/S0140-6736(24)02600-X","volume":"404","author":"JD Schoenfeld","year":"2025","unstructured":"Schoenfeld JD, Haas-Kogan DA, O'Neill AF. \u00a0Abscopal response in a patient with fibrolamellar hepatocellular carcinoma following radiotherapy. Lancet. 2025;404:2603\u20134.","journal-title":"Lancet"},{"key":"1456_CR59","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S2468-1253(22)00339-9","volume":"8","author":"CL Chiang","year":"2023","unstructured":"Chiang CL, Chiu KWH, Chan KSK, Lee FAS, Li JCB, Wan CWS, et al. Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial. Lancet Gastroenterol Hepatol. 2023;8:169\u201378.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1456_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47420-3","volume":"15","author":"Z Li","year":"2024","unstructured":"Li Z, Liu J, Zhang B, Yue J, Shi X, Cui K, et al. Neoadjuvant tislelizumab plus stereotactic body radiotherapy and adjuvant tislelizumab in early-stage resectable hepatocellular carcinoma: the Notable-HCC phase 1b trial. Nat Commun. 2024;15:3260.","journal-title":"Nat Commun"},{"key":"1456_CR61","doi-asserted-by":"publisher","first-page":"e005457","DOI":"10.1136\/jitc-2022-005457","volume":"10","author":"M de la Torre-Al\u00e1ez","year":"2022","unstructured":"de la Torre-Al\u00e1ez M, Matilla A, Varela M, I\u00f1arrairaegui M, Reig M, Lled\u00f3 JL, et al. Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study. J Immunother Cancer. 2022;10:e005457.","journal-title":"J Immunother Cancer"},{"key":"1456_CR62","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.ijrobp.2023.07.001","volume":"118","author":"C Ning","year":"2024","unstructured":"Ning C, Zhang X, Wang Y, Yang X, Yang X, Chao J,\u00a0et al. Radiation therapy with combination therapy of immune checkpoint inhibitors and antiangiogenic therapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2024;118:1461\u201371.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1456_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1790936","volume":"17","author":"Z Liu","year":"2026","unstructured":"Liu Z, Liu J, Chu H, Lu Z, Xu S, Qin Y, et al. JAK inhibition in PD-1 immunotherapy and tumor microenvironment. Front Immunol. 2026;17:1790936.","journal-title":"Front Immunol"},{"key":"1456_CR64","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41586-024-07962-4","volume":"634","author":"B Feng","year":"2024","unstructured":"Feng B, Bai Z, Zhou X, Zhao Y, Xie YQ, Huang X, et al. The type 2 cytokine Fc-IL-4 revitalizes exhausted CD8+ T cells against cancer. Nature. 2024;634:712\u201320.","journal-title":"Nature"},{"key":"1456_CR65","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41586-024-07762-w","volume":"634","author":"Z Bai","year":"2024","unstructured":"Bai Z, Feng B, McClory SE, de Oliveira BC, Diorio C, Gregoire C, et al. Single-cell CAR T atlas reveals type 2 function in 8-year leukemia remission. Nature. 2024;634:702\u201311.","journal-title":"Nature"},{"key":"1456_CR66","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41586-024-08194-2","volume":"637","author":"M Wagner","year":"2025","unstructured":"Wagner M, Nishikawa H, Koyasu S. Reinventing type 2 immunity in cancer. Nature. 2025;637:296\u2013303.","journal-title":"Nature"},{"key":"1456_CR67","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41392-024-01752-0","volume":"9","author":"J Zhou","year":"2024","unstructured":"Zhou J, Liu J, Wang B, Li N, Liu J, Han Y, et al. Eosinophils promote CD8+ T-cell memory generation to potentiate antibacterial immunity. Signal Transduct Target Ther. 2024;9:43.","journal-title":"Signal Transduct Target Ther"},{"key":"1456_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59147-w","volume":"16","author":"A Koester","year":"2025","unstructured":"Koester A, Witcher DR, Lee M, Demarest SJ, Potter S, Werle K, et al. Ucenprubart is an agonistic antibody to CD200R with the potential to treat inflammatory skin disease: preclinical development and a phase 1 clinical study. Nat Commun. 2025;16:4082.","journal-title":"Nat Commun"},{"key":"1456_CR69","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2024.2410316","volume":"16","author":"C Melero","year":"2024","unstructured":"Melero C, Budiardjo SJ, Daruwalla A, Larrabee L, Ganichkin O, Heiler AJ, et al. Huang YM. CD200R1 immune checkpoint blockade by the first-in-human anti-CD200R1 antibody 23ME-00610: molecular mechanism and engineering of a surrogate antibody. MAbs. 2024;16:2410316.","journal-title":"MAbs"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01456-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01456-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01456-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T22:02:26Z","timestamp":1788127346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01456-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":69,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1456"],"URL":"https:\/\/doi.org\/10.1038\/s41423-026-01456-1","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}